Edwards Lifesciences Corp (EW) › Operating IncomeEdwards Lifesciences Corp (EW) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: $751.20M2017: $1.09B2018: $748.20M2019: $1.15B2020: $897.60M2021: $1.69B2022: $1.50B2023: $1.31B2024: $1.38B2025: $1.26B$1.26B2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$1.26B-8.3%2024$1.38B+5.3%2023$1.31B-12.6%2022$1.50B-11.4%2021$1.69B+88.3%2020$897.60M-21.7%2019$1.15B+53.3%2018$748.20M-31.3%2017$1.09B+45.0%2016$751.20M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share